ISPOR Announces 2019-2020 Board of Directors

Nancy J. Devlin, PhD Moves Into the Role of President


  • newswise-fullscreen ISPOR Announces 2019-2020 Board of Directors

    ISPOR 2019-2020 Board of Directors

Newswise — Lawrenceville, NJ, USA—June 10, 2019—ISPOR, the professional society for health economics and outcomes research (HEOR), announced the results of its recent elections and its 2019-2020 Board of Directors. The Society’s membership selects its new president-elect and the 2019-2020 board will assume office on July 1, 2019. 

Nancy J. Devlin, PhD—President Dr Devlin will assume the role of 2019-2020 president after serving as ISPOR’s president-elect over the past year. She is director, Centre for Health Policy at the University of Melbourne in Melbourne, Victoria, Australia. 

Jens Grueger, PhD—President-Elect Dr Grueger was elected president-elect and will move into the role of president during the 2020-2021 term. Most recently he was head of Global Access at F. Hoffmann-La Roche in Basel, Switzerland. 

Federico Augustovski, MD, MSc, PhD—Immediate Past President Dr Augustovski moves into the role of past president and is director of health economic evaluations and technology assessment at the Institute for Clinical Effectiveness and Health Policy in Buenos Aires, Argentina.

Returning board members include: 

Meindert Boysen, PharmD—Director Dr Boysen is director, technology appraisal and highly-specialized technologies programs at the National Institute for Health and Care Excellence, London, England, UK. 

Jalpa A. Doshi, PhD—Director Dr Doshi is professor of medicine at the University of Pennsylvania, Philadelphia, PA, USA. 

Stephanie R. Earnshaw, PhD—Director Dr Earnshaw is senior vice president, health economics at RTI Health Solutions, Research Triangle Park, NC, USA. 

Jan Elias Hansen, PhD—Director Dr Hansen is vice president, Evidence for Access Unit, US Medical Affairs at Genentech, South San Francisco, CA, USA. 

Neil Hawkins, MSc, MBA, PhD—Director Dr Hawkins is professor of health technology assessment at the University of Glasgow, Glasgow, Scotland, UK. 

Rok Hren, PhD, MSc—Director Dr Hren is head of laboratory diagnostics, point.of.care and molecular diagnostics in the Adriatic region, Siemens Healthineers, Ljubljana, Slovenia. 

Zeba M. Khan, RPh, PhD—Treasurer Dr Khan is vice president at Celgene Corporation, Summit, NJ, USA. 

Raoh-Fang (Jasmine) Pwu, PhD—Director Dr Pwu is director, National Hepatitis C Program Office, Ministry of Health and Welfare, Taipei, Taiwan.
 

###

ABOUT ISPOR
ISPOR, the professional society for health economics and outcomes research (HEOR), is an international, multistakeholder, nonprofit dedicated to advancing HEOR excellence to improve decision making for health globally. The Society is the leading source for scientific conferences, peer-reviewed and MEDLINE®-indexed publications, good practices guidance, education, collaboration, and tools/resources in the field.
Web: www.ispor.org | LinkedIn: www.linkedin.com/company/ispororg | Twitter: www.twitter.com/ispororg (@ISPORorg) | YouTube: www.youtube.com/ispororg | Facebook: www.facebook.com/ispororg | Instagram: www.instagram.com/ispororg

  • share-facebook-ISPOR Announces 2019-2020 Board of Directors
  • share-twitter-ISPOR Announces 2019-2020 Board of Directors

Comment/Share

Chat now!